Tower Research Capital LLC (TRC) - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 70 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,209
+126.2%
30,904
+26.0%
0.00%
Q2 2023$4,071
+31215.4%
24,525
+80.8%
0.00%
Q1 2023$13
+8.3%
13,564
+16.0%
0.00%
Q4 2022$12
-100.0%
11,696
-45.8%
0.00%
Q3 2022$25,00021,581
+9665.2%
0.00%
Q2 2022$0
-100.0%
221
-73.4%
0.00%
Q1 2022$3,000
+50.0%
832
+108.0%
0.00%
Q4 2021$2,000400
+19900.0%
0.00%
Q3 2021$0
-100.0%
2
-100.0%
0.00%
-100.0%
Q2 2021$44,000
+51.7%
11,557
+3.7%
0.00%
Q1 2021$29,000
-29.3%
11,147
-31.4%
0.00%
-100.0%
Q4 2020$41,000
-66.1%
16,241
-72.2%
0.00%0.0%
Q3 2020$121,000
+278.1%
58,487
+458.2%
0.00%0.0%
Q2 2020$32,000
+300.0%
10,478
+366.9%
0.00%0.0%
Q4 2019$8,000
+100.0%
2,244
+106.8%
0.00%
Q3 2019$4,000
-85.7%
1,085
-81.5%
0.00%
-100.0%
Q2 2019$28,000
+1300.0%
5,874
+1074.8%
0.00%
Q1 2019$2,000
-77.8%
500
-86.2%
0.00%
-100.0%
Q4 2018$9,0000.0%3,623
+111.3%
0.00%0.0%
Q3 2018$9,000
+800.0%
1,715
+784.0%
0.00%
Q1 2018$1,000
-95.8%
194
-95.4%
0.00%
-100.0%
Q3 2017$24,000
+2300.0%
4,180
+1495.4%
0.00%
Q1 2017$1,000262
+1355.6%
0.00%
Q4 2016$0
-100.0%
18
-99.4%
0.00%
-100.0%
Q3 2016$6,000
+500.0%
3,199
+593.9%
0.00%
Q2 2016$1,000
-50.0%
461
-52.5%
0.00%
Q1 2016$2,000
+100.0%
971
+94.2%
0.00%
Q2 2015$1,0005000.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders